Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 01/05/23 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 11/04/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/07/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 07/01/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 06/29/22 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 05/26/22 | Statement of changes in beneficial ownership of securities |
|
1 |